These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 6721807)

  • 21. Standardized method of aerosol challenge for testing the efficacy of Mycoplasma gallisepticum vaccines.
    Whithear KG; Harrigan KE; Kleven SH
    Avian Dis; 1996; 40(3):654-60. PubMed ID: 8883797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterins and vaccines for the control of Mycoplasma gallisepticum.
    Kleven SH; Glisson JR; Lin MY; Talkington FD
    Isr J Med Sci; 1984 Oct; 20(10):989-91. PubMed ID: 6548986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of chickens with temperature-sensitive mutants of Mycoplasma gallisepticum.
    Lam KM; Lin WQ; Yamamoto R; Farver TB
    Avian Dis; 1983; 27(3):803-12. PubMed ID: 6227317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Mycoplasma gallisepticum growth and attachment to chick tracheal rings by antibodies to a 64-kilodalton membrane protein of M. gallisepticum.
    Avakian AP; Ley DH
    Avian Dis; 1993; 37(3):706-14. PubMed ID: 8257360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virulence of Mycoplasma synoviae strains in experimentally infected broiler chickens.
    Hinz KH; Blome C; Ryll M
    Berl Munch Tierarztl Wochenschr; 2003; 116(1-2):59-66. PubMed ID: 12592932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycoplasma gallisepticum (MG)--laboratory and field studies evaluating the safety and efficacy of an inactivated MG bacterin.
    Hildebrand DG; Page DE; Berg JR
    Avian Dis; 1983; 27(3):792-802. PubMed ID: 6688951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of infection route and concurrent infectious bronchitis virus vaccination on Mycoplasma gallisepticum disease pathology in an experimental model.
    Leigh SA; Branton SL; Evans JD; Collier SD
    Avian Pathol; 2012 Oct; 41(5):497-503. PubMed ID: 23025670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of protection against Mycoplasma gallisepticum infection in chickens vaccinated with the F strain of M. gallisepticum.
    Cummings TS; Kleven SH
    Avian Dis; 1986; 30(1):169-71. PubMed ID: 3729860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of F strain Mycoplasma gallisepticum isolates by detection of an immunoreactive protein.
    Thomas CB; Sharp P; Fritz BA; Yuill TM
    Avian Dis; 1991; 35(3):601-5. PubMed ID: 1953583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of infectious bronchitis strains and vaccines on the incidence of Mycoplasma synoviae airsacculitis.
    Hopkins SR; Yoder HW
    Avian Dis; 1982; 26(4):741-52. PubMed ID: 6297445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunity to mycoplasma infections of the respiratory system in the domestic fowl and turkey.
    Jordan FT
    Dev Biol Stand; 1975; 28():590-6. PubMed ID: 1126586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of Mycoplasma gallisepticum.
    Soeripto ; Whithear KG; Cottew GS; Harrigan KE
    Aust Vet J; 1989 Mar; 66(3):73-7. PubMed ID: 2540737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of harderian glands in resistance against Mycoplasma gallisepticum challenge.
    Karaca K; Lam KM; Bickford AA
    Res Vet Sci; 1989 Nov; 47(3):323-6. PubMed ID: 2595091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of a temperature-sensitive clone of Mycoplasma synoviae as a live vaccine.
    Markham JF; Morrow CJ; Scott PC; Whithear KG
    Avian Dis; 1998; 42(4):677-81. PubMed ID: 9876835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of a temperature sensitive mutant Mycoplasma gallisepticum vaccine.
    Whithear KG; Soeripto ; Harrigan KE; Ghiocas E
    Aust Vet J; 1990 May; 67(5):168-74. PubMed ID: 2143068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temperature-sensitive mutant of Mycoplasma synoviae. I. Production and selection of a nonpathogenic but immunogenic clone.
    Nonomura I; Imada Y
    Avian Dis; 1982; 26(4):763-75. PubMed ID: 7159319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duration of protective immunity induced by Mycoplasma gallisepticum strain ts-304 vaccine in chickens.
    Kanci Condello A; Kulappu Arachchige SN; Shil PK; Underwood GJ; Noormohammadi AH; Markham PF; Wawegama NK; Browning GF
    Vet Microbiol; 2020 Dec; 251():108883. PubMed ID: 33069036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examination of Mycoplasma gallisepticum isolates from chickens with respiratory disease in a commercial flock vaccinated with a living M. gallisepticum vaccine.
    Whithear KG; Ghiocas E; Markham PF; Marks D
    Aust Vet J; 1990 Dec; 67(12):459-60. PubMed ID: 2076073
    [No Abstract]   [Full Text] [Related]  

  • 39. Virulence and transmissibility of Mycoplasma gallisepticum.
    Soeripto ; Whithear KG; Cottew GS; Harrigan KE
    Aust Vet J; 1989 Mar; 66(3):65-72. PubMed ID: 2712773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of the avirulent Mycoplasma gallisepticum strain K5054 as a live vaccine in poultry.
    Ferguson NM; Leiting VA; Klevena SH
    Avian Dis; 2004; 48(1):91-9. PubMed ID: 15077802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.